Home
About
Brain Health
Programs
The Alliance
News & Events
Careers
Donate
Contact

Home
About
Brain Health
Programs
The Alliance
News & Events
Careers
Donate
Contact

Home

Cohen Veterans Bioscience

CVB 2019 Impact Report

Driving Progress on Veterans Brain Health

Landmark Study Identifies Six Genetic Markers of Post- Traumatic Stress Disorder (PTSD) Risk

Driving Progress on Veterans Brain Health

State of the Science Summit

RAPID-Dx

Press Release: Cohen Veterans Bioscience Issues National PTSD Awareness Day Progress Report

Announcing the Inaugural State of the Science Summit Proceedings

Study Identifies Post-Traumatic Stress Disorder (PTSD) Brain Imaging Biomarker

Cohen Veterans Bioscience - Advancing Brain Health

RECENT NEWS

Cohen Veterans Bioscience 2019 Impact Report
December 20, 2019
Cohen Veterans Bioscience and Parexel Biotech Collaborate on Landmark Adaptive Platform Trial Studying Posttraumatic Stress Disorder (PTSD) Pharmacotherapeutics
November 11, 2019

GET UPDATES

Leave this field empty if you're human:

Help us fast-track diagnostics and treatments for Post-Traumatic Stress Disorder (PTSD) & Traumatic Brain Injury (TBI).

Advancing Brain Health

We are dedicated to fast-tracking the development of diagnostic tests and personalized therapeutics for the millions of veterans and civilians who suffer the devastating effects of trauma to the brain.

PTSD

1 in 5 Veterans of the Iraq & Afghanistan wars have been diagnosed with PTSD.
8% of people have PTSD at some point during their lives.

TBI

There are 1.7 Million Traumatic Brain Injuries in the United States every year.
5.3 Million suffer from TBI-induced disabilities.

DONATE

100% of your donation funds our research programs.
Our administrative expenses are funded by a generous grant from Steven A. Cohen.

We Need Precision Medicine for The Brain

We bring together the brightest minds and deploy the most innovative scientific tools with an emphasis on scale, risk-minimization, efficiency and speed.

Recent Highlights

Cohen Veterans Bioscience and Parexel Biotech Collaborate on Landmark Adaptive Platform Trial Studying Posttraumatic Stress Disorder (PTSD) Pharmacotherapeutics

Cohen Veterans Bioscience and Parexel Biotech Collaborate on Landmark Adaptive Platform Trial Studying Posttraumatic Stress Disorder (PTSD) Pharmacotherapeutics

Driving Progress on Veterans Brain Health

Driving Progress on Veterans Brain Health

Landmark Study Identifies Six Genetic Markers of Post- Traumatic Stress Disorder (PTSD) Risk

Landmark Study Identifies Six Genetic Markers of Post-Traumatic Stress Disorder (PTSD) Risk

Press Release: Cohen Veterans Bioscience Issues National PTSD Awareness Day Progress Report

Cohen Veterans Bioscience Issues National PTSD Awareness Day Progress Report

News

Cohen Veterans Bioscience 2019 Impact Report
Learn about our latest partnerships, program updates and more in our 2019 Impact Report.

December 20, 2019

Events

Driving Progress on Veterans Brain Health
Cohen Veterans Bioscience would like to honor our military veterans by highlighting the ways we are transforming science to advance brain health.

November 11, 2019

Help Us Make Brain Disorders Predictable, Treatable & Curable

WHO WE ARE

Cohen Veterans Bioscience is a national nonprofit 501(c)(3) public charity research organization dedicated to fast-tracking the development of diagnostic tests and personalized therapeutics for the millions of veterans and civilians who suffer the devastating effects of trauma-related and other brain disorders.

Learn More Donate

LEARN MORE ABOUT OUR MISSION

Get news & updates

Leave this field empty if you're human:

©2020 Cohen Veterans Bioscience
Powered by Tone Creative

Privacy Policy
Terms of Use
Indirect Cost Policy
Careers
Contact Us
Donate